课题基金 / 基金详情

项目摘要

项目成果

HONGJU WU的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 细胞治疗是治疗胰岛素缺乏性糖尿病的一种很有前途的策略。其中之一 在过去的十年里,这种胰岛移植策略取得了显著的成功, 但由于胰岛供应和移植物存活,其使用受到限制。另一种基于细胞的策略是 从其他类型的细胞再生产生胰岛素的β细胞。在初步研究中,我们 探索了一种从邻近的产生胰升糖素的β细胞再生α细胞的策略 胰岛。具体地说,我们研究了Pax4,一种关键的转录因子 为此目的,在发育过程中确定α-VSβ-细胞谱系。我们的数据显示 将Pax4基因转入α克隆细胞系α-TC1.9细胞,诱导其采用β-细胞 表型。我们还发现,将Pax4基因转移到原代人胰岛中显著改善了 β-细胞功能,并有间接证据表明,Pax4不仅促进β-细胞 存活,还能诱导α细胞向β细胞转化。尽管进行了广泛的初步研究, 需要更多的研究才能充分发挥Pax4和Pax4的治疗潜力 彻底了解它的行为。因此,我们在这个项目中提出了两个具体目标:1) 研究Pax4基因转移到供体人胰岛是否提高了治疗效果 胰岛移植的疗效;2)研究Pax4是否诱导α-to-β细胞 使用谱系追踪技术在原发胰岛和体内进行转化。显然,这个项目 将提供有关Pax4的治疗作用和潜力的重要信息 糖尿病治疗。
英文摘要
SUMMARY Cell-based therapy is promising strategy for the cure of insulin deficient diabetes. One of such strategies, islet transplantation, has achieved remarkable success over the past decade, but its use is limited due to islet supply and graft survival. Another cell-based strategy is to regenerate the insulin-producing β-cells from other cell types. In the preliminary studies, we explored a strategy to regenerate β-cells from the neighboring glucagon-producing α-cells in pancreatic islets. Specifically, we explored Pax4, a transcription factor critical for the determination of α- vs β-cell lineage during development, for this purpose. Our data showed Pax4 gene transfer into αTC1.9 cells, a clonal α-cell line, induced them to adopt β-cell phenotype. We also found Pax4 gene transfer into primary human islets significantly improved β-cell function, and had circumstantial evidence indicating Pax4 not only promoted β-cell survival, but also induced α-to-β cell conversion. Despite the extensive preliminary studies, more investigations are required in order to fully realize the therapeutic potential of Pax4 and to thoroughly understand its actions. We thus propose two specific aims in this project: 1) To investigate whether Pax4 gene transfer into donor human islets improves the therapeutic efficacy of islet transplantation; and 2) To investigate whether Pax4 induces α-to-β cell conversion in primary islets and in vivo using lineage-tracing technology. Clearly, the project will provide important information regarding the therapeutic actions and potential of Pax4 for diabetes treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pax4-induced alpha-to-beta cell conversion
  • 批准号:
    9173658
  • 项目类别:
  • 资助金额:
    $33.86万
  • 财政年份:
    2016
  • 负责人:
    HONGJU WU
  • 依托单位:
Improving Islet Transplantation Outcome With Akt1
  • 批准号:
    8545473
  • 项目类别:
  • 资助金额:
    $0.15万
  • 财政年份:
    2012
  • 负责人:
    HONGJU WU
  • 依托单位:
Improving Islet Transplantation Outcome With Akt1
  • 批准号:
    8245116
  • 项目类别:
  • 资助金额:
    $32.08万
  • 财政年份:
    2009
  • 负责人:
    HONGJU WU
  • 依托单位:
Improving Islet Transplantation Outcome With Akt1
海外基金